Search Results

Lin Chen has worked as a Nurse Practitioner in Medical Oncology since 2021. She earned her first bachelor’s degree in Psychology at the University of the South and a second bachelor’s degree in Nursing at Johns Hopkins University. She has over 9 years of nursing experience within the acute care setting before earning her Master…

A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination with Osimertinib in Patients with Advanced, EGFR-Mutant, Metastatic Non-Small Cell Lung Cancer who have Progressed after Treatment with Osimertinib (ONC-003) MOA: Quaratusugene ozeplasmid is a nanoparticle encapsulating an optimized TUSC2 expression plasmid. Decreased expression of TUSC2 is associated with worse OS.…

A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and Postoperative Trastuzumab-based Therapy (FLAMINGO-01) MOA: GLSI-100 is the intradermal administration of GP2, a HER2/neu protein, and GM-CSF. GLSI-100 induces a CD8+…

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry) Brief Summary:  The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary…

Jaynah Mistry is a physician assistant with over 8 years of experience in inpatient hospital medicine. She graduated with her master’s degree from Rochester Institute of Technology in 2016. She has been with MOH since January of 2022.